{
    "clinical_study": {
        "@rank": "95679", 
        "arm_group": [
            {
                "arm_group_label": "Cereve Sleep System at 14-16 degrees C.", 
                "arm_group_type": "Active Comparator", 
                "description": "Active"
            }, 
            {
                "arm_group_label": "Cereve Sleep System at 30 degrees C", 
                "arm_group_type": "Active Comparator", 
                "description": "Active"
            }
        ], 
        "brief_summary": {
            "textblock": "Insomnia patients demonstrate subjective and physiological hyperarousal.  The Cereve Sleep\n      System has been proposed as a clinical treatment to reverse this hyperarousal in insomnia\n      patients.  The current study is a two dose study to determine the optimal temperature for\n      the Cereve Sleep System.  Primary outcome measures include EEG sleep measured sleep latency\n      and sleep efficiency."
        }, 
        "brief_title": "Comparison of Two Temperatures to Treat Insomnia", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Primary Insomnia", 
        "condition_browse": {
            "mesh_term": "Sleep Initiation and Maintenance Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Age >/= 22\n\n        Diagnosis of  insomnia that meets criteria for DSM IV diagnosis of primary insomnia and\n        International Classification of Sleep Disorders (ICSD)general insomnia criteria and RDC\n        insomnia disorder criteria\n\n        Subjects must remain alcohol-free and avoid drugs that could affect sleep during the\n        study.\n\n        >14 on the Insomnia Severity Index\n\n        Sleep -Wake diaries demonstrate sleep efficiency <85% on at least 50% of nights\n\n        Exclusion Criteria:\n\n        Neuropsychiatric disorders that may independently affect sleep, brain function or\n        cognition, such as current major syndromal psychiatric disorders, including DSM-IV mood,\n        anxiety, psychotic, and substance use disorders.\n\n        Specific exclusionary diagnoses include major depressive disorder, dysthymic disorder,\n        bipolar disorder, panic disorder, obsessive compulsive disorder, generalized anxiety\n        disorder, any psychotic disorder, and any current substance use disorder.\n\n        Unstable medical conditions Raynaud's Disease\n\n        Irregular sleep schedules including shift workers;\n\n        A latency to persistent sleep < 15 on either the sleep disorder screening night or the\n        baseline PSG sleep night;\n\n        A sleep efficiency > 85% on either the sleep disorder screening night or the baseline PSG\n        sleep night;\n\n        An AHI (apnea hypopnea index) > 10 and/or a periodic limb movement arousal index (PLMAI) >\n        15 from SN1\n\n        Body Mass Index  >34\n\n        Use of medications known to affect sleep or wake function\n\n        Consumption of more than one alcoholic drink per day, or more than 7 drinks per week prior\n        to study entry.\n\n        Caffeinated beverages > 4/day or the equivalent of more than 4 cups of coffee Unable to\n        read or understand English"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "144", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01790256", 
            "org_study_id": "Cereve CIP-003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cereve Sleep System at 14-16 degrees C.", 
                "intervention_name": "Cereve Sleep System at 30 degrees C", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Cereve Sleep System at 30 degrees C", 
                "intervention_name": "Cereve Sleep System at 14-16 degrees C", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "September 17, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72211"
                    }, 
                    "name": "Paul Wylie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Timothy Grant"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pembroke Pines", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33026"
                    }, 
                    "name": "David Seiden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33707"
                    }, 
                    "name": "Neil Feldman"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "Alan Lankford"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "Russell Rosenberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Crestview Hills", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "41047"
                    }, 
                    "name": "David Mayleben"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63143"
                    }, 
                    "name": "Mark Muehlbach"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75231"
                    }, 
                    "name": "Leon Rosenthal"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multi-center Prospective, Blinded, Randomized Crossover Study to Compare the Cer\u00eave Sleep System at Two Different Temperatures in Primary Insomnia Patients", 
        "overall_official": [
            {
                "affiliation": "Sleep Center of Georgia", 
                "last_name": "Alan Lankford, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "NeuroTrials", 
                "last_name": "Russell Rosenberg, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sleep Medicine Associates of Texas", 
                "last_name": "Leon Rosenthal, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Community Research", 
                "last_name": "David Mayleben, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Preferred Research Partners", 
                "last_name": "Paul Wylie, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clayton Sleep Institute", 
                "last_name": "Mark Muehlbach, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Broward Research Group", 
                "last_name": "David Seiden, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Miami Research Associates", 
                "last_name": "Timothy Grant, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Clinical Research Group of St. Petersburg", 
                "last_name": "Neil Feldman, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Polysomnographically determined sleep parameters", 
                "measure": "Polysomnographically determined sleep latency as changed from baseline measures", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }, 
            {
                "measure": "Poloysomnographically determined sleep efficiency as changed from baseline measures", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01790256"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cereve, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cereve, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}